scispace - formally typeset
H

Hongwu Wang

Researcher at Huazhong University of Science and Technology

Publications -  31
Citations -  7320

Hongwu Wang is an academic researcher from Huazhong University of Science and Technology. The author has contributed to research in topics: Hepatitis & Cytotoxic T cell. The author has an hindex of 10, co-authored 31 publications receiving 5347 citations.

Papers
More filters
Journal ArticleDOI

Clinical and immunological features of severe and moderate coronavirus disease 2019.

TL;DR: The SARS-CoV-2 infection may affect primarily T lymphocytes particularly CD4+T and CD8+ T cells, resulting in decrease in numbers as well as IFN-γ production, which may be of importance due to their correlation with disease severity in COVID-19.
Journal ArticleDOI

Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study.

TL;DR: Severe acute respiratory syndrome coronavirus 2 infection can cause both pulmonary and systemic inflammation, leading to multi-organ dysfunction in patients at high risk, including patients with cardiovascular comorbidity.
Posted ContentDOI

Clinical and immunologic features in severe and moderate forms of Coronavirus Disease 2019

TL;DR: The SARS-CoV-2 infection may affect primarily T lymphocytes, particularly CD4+T cells, resulting in significant decrease in number as well as IFN-γ production, which may be associated with disease severity in COVID-19.
Journal ArticleDOI

Increased Killing of Liver NK Cells by Fas/Fas Ligand and NKG2D/NKG2D Ligand Contributes to Hepatocyte Necrosis in Virus-Induced Liver Failure

TL;DR: NK cells play a pivotal role in the pathogenesis of FHF and HBV-ACLF, in which process Fas/FasL and NKG2D/NKG 2D ligand pathway contribute to the liver NK cell-mediated hepatocyte injury.
Journal ArticleDOI

Non-alcoholic hepatic steatosis attenuates hepatitis B virus replication in an HBV-immunocompetent mouse model.

TL;DR: In an HBV-immunocompetent mouse model, non-alcoholic hepatic steatosis inhibited HBV replication, as indicated by the reduction of HBV DNA andHBV-related antigens.